Beyond Health Insurance: Public Policy to Improve Health
Robert Kaestner, Anthony Lo Sasso, Lorens Helmchen
Emerald Group Publishing, Oct 13, 2008 - Medical - 206 pages
Much of the debate about health policy in the United States has focused on the availability of health insurance coverage and the relatively large number of individuals who are uninsured. While tackling the problem of the uninsured might improve access to and utilization of health care, it would likely have little effect on the health of the population, as there is only a weak connection between health insurance coverage and health. Expanding health insurance coverage alone is unlikely to significantly improve the health of the population or narrow health disparities within the population, given that many of the major causes of poor health such as smoking, obesity, and physical inactivity are largely unaffected by health insurance. The narrow focus on the uninsured in the health policy debate comes at the expense of other policies that could improve health faster and more significantly for every dollar spent. It is well known that the United States spends approximately twice as much per capita on health care as most other developed nations, but that there is little difference in population health between the United States and other developed nations. This suggests that we are on the 'flat part of the curve' of health care spending with respect to health and as a result need to pursue other approaches for improving population health. In light of the imbalance in the health policy debate in the US, in November 2007, the Institute of Government and Public Affairs and the College of Medicine of the University of Illinois sponsored a conference entitled, Beyond Health Insurance: Public Policy to Improve Health. The purpose of the conference was to make available to the public new research on policies that can significantly improve the health of the US population. The conference focused on four areas: reducing racial and ethnic health disparities, preventing disease and promoting health, developing and regulating pharmaceuticals, and improving consumer information.
What people are saying - Write a review
We haven't found any reviews in the usual places.
what will it takequest
Chapter 3 Influence information overload and information technology in health care
Chapter 4 Health disparities and directtoconsumer advertising of pharmaceutical products
a first look
Chapter 6 Spillover effects of prescription drug withdrawals
Chapter 7 The psychology of nutrition messages
Chapter 8 Evaluation criteria for report cards of healthcare providers
Implications for Clinical Practice and Public Policy
Other editions - View all
age at death analysis anti-obesity drugs assess associated cancer cholesterol clinical competitive benefits consumers cost decision support technology diet diffusion direct-to-consumer disease drug vintage drug withdrawals DTC advertising effects erectile dysfunction estimates evaluation evidence example FQHCs genomic diagnostics health disparities Health Economics health expenditures health insurance health outcomes heuristic hijacking hypertension impact Improve Health innovation interventions Journal LexisNexis Lichtenberg Maciosek Mathios mean age mean vintage measure Medicine MEPS negative spillovers newer drugs NHEA non-withdrawn drugs nutrient nutrition obesity overall patients percent personalized medicine pharmaceutical pharmacogenomic physicians population potential prescription drug primary prevention providers public health messages PubMed recommendations relevant remaining drugs report cards respondents risk adjustment screening secondary prevention socially disadvantaged specific statistical Table therapeutic class trastuzumab treatment trends utilization variable Vioxx withdrawn drug